Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for B2URE3

Entry ID Method Resolution Chain Position Source
AF-B2URE3-F1 Predicted AlphaFoldDB

No variants for B2URE3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B2URE3

No associated diseases with B2URE3

1 regional properties for B2URE3

Type Name Position InterPro Accession
domain Aspartate/glutamate/uridylate kinase 28 - 270 IPR001048

Functions

Description
EC Number 2.7.2.8 Phosphotransferases with a carboxy group as acceptor
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
acetylglutamate kinase activity Catalysis of the reaction: ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L-glutamate-5-phosphate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

2 GO annotations of biological process

Name Definition
arginine biosynthetic process via ornithine The chemical reactions and pathways resulting in the formation of arginine (2-amino-5-guanidinopentanoic acid) via the intermediate compound ornithine.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MDSKITRLIE QASVIVGALP YLQAYRDKTF LIKFGGSAMD DARLVKKLMR DIVLLEVLGF
70 80 90 100 110 120
NPVIVHGGGK AISKAMAEAG LEARFVNGLR VTTPEAISIV ERTLSGTINP GLVQMFRDYG
130 140 150 160 170 180
GKGVGIPGTE IFVGERIHEK DEQGNPIDIG EVGNVIGCLT ERITEALELQ ITPIVSPLAK
190 200 210 220 230 240
ELGTHKPLNV NADLAAAALA KELKPVKLIY ISDVPGIMKD PSDPSTLIKS VTRTEALDLI
250 260 270 280 290
KDGTVSGGMI PKIHSAIDAL NAGVRKVHFI DGRLPHTLLL EIFTPDGIGT EIIREQR